Through balanced activity of bone-forming osteoblasts and bone-resorbing osteoclasts, the skeletal system undergoes continuous remodeling. Structural integrity is maintained and responses to mechanical forces occur through this dynamic process.
Bone Remodeling Mechanisms
By cellular interactions, bone tissue constantly undergoes remodeling governed. Using various molecular tools, complex signaling pathways involved in this equilibrium are investigated by researchers.
Peptides in Skeletal Research
Bone Morphogenetic Proteins (BMPs)
In developmental biology, BMPs play roles as growth factors. In laboratory models examining bone formation pathways and cellular differentiation processes, BMP-2 and BMP-7 are studied.
Body Protection Compound 157 (BPC-157)
In animal research models, a synthetic peptide sequence is investigated. Its interactions with various cellular systems and its presence in tissue samples are examined by studies.
Ipamorelin
For its receptor binding properties and signaling characteristics in laboratory settings, a member of the growth hormone-releasing peptide (GHRP) family is studied.
Insulin-Like Growth Factor-1 (IGF-1)
Primarily in hepatic tissue in response to growth hormone, a peptide hormone is produced. For its role in cellular proliferation and differentiation pathways, IGF-1 is studied extensively.
Parathyroid Hormone (PTH)
Calcium and phosphorus homeostasis is regulated by PTH, secreted by parathyroid glands. How different administration patterns affect osteoblast activity in experimental models has been characterized by research.
Thymosin Beta-4 (Tβ4)
Examining cellular migration and differentiation patterns, Tβ4 has been investigated in laboratory models.
References:
- Lee, S.-I. et al. (2016). Thymosin Beta-4 in cellular models. PLoS One, 11(1), e0146708.
- Johansen, P. B. et al. (1999). Ipamorelin receptor characterization. Growth Horm IGF Res, 9(2), 106-113.
- Sampath, T. K., & Vukicevic, S. (2020). Biology of bone morphogenetic proteins. Bone, 141, 115602.
- Sebecić, B. et al. (1999). Peptide effects in bone models. Bone, 24(3), 195-202.
- Svensson, J. et al. (2000). GH secretagogue effects in research models. J Endocrinol, 165, 569-577.
